SCHEMBL8399290

SCHEMBL8399290

CCOC(=O)c1cnc(Cc2ccc(Cl)c(Cl)c2)nc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.49
▸ KDM4E B2RXH2 1/20 0.49
▸ TSHR P16473 2/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ CYP4F2 P78329 1/20 0.48
▸ CYP4A11 Q02928 1/20 0.48
▸ CYP1A2 P05177 1/20 0.47
▸ MAOB P27338 1/20 0.47
▸ KMT2A Q03164 3/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ MAPT P10636 3/20 0.46
▸ HPGD P15428 2/20 0.46
▸ GAA P10253 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ GFER P55789 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.43
▸ FOS P01100 1/20 0.42
▸ JUN P05412 1/20 0.42
▸ NFKB1 P19838 1/20 0.42
▸ NFKB2 Q00653 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8396925 0.89 CYP4F2 (0.47) ALDH1A1KDM4ETSHRSMN1; SMN2CYP4F2
SCHEMBL8395191 0.85 FOS (0.48) ALDH1A1KDM4ETSHRSMN1; SMN2CYP4F2
SCHEMBL7726224 0.79 ALDH1A1 (0.56) ALDH1A1KDM4ETSHRSMN1; SMN2KMT2A
SCHEMBL9589692 0.77 HSP90AA1 (0.55) ALDH1A1KDM4ETSHRSMN1; SMN2CYP1A2
SCHEMBL4139836 0.77 ALDH1A1 (0.54) ALDH1A1KDM4ETSHRSMN1; SMN2KMT2A
SCHEMBL13447383 0.77 ALDH1A1 (0.54) ALDH1A1KDM4ETSHRSMN1; SMN2KMT2A
SCHEMBL16682717 0.76 ALDH1A1 (0.53) ALDH1A1KDM4ETSHRSMN1; SMN2KMT2A
SCHEMBL9589351 0.75 ALDH1A1 (0.52) ALDH1A1KDM4ESMN1; SMN2CYP1A2KMT2A
SCHEMBL4513057 0.74 SMN1; SMN2 (0.44) ALDH1A1KDM4ETSHRSMN1; SMN2CYP4F2
SCHEMBL4512178 0.74 KDM4E (0.58) ALDH1A1KDM4ETSHRSMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5935966-A COMPOUNDS THAT BLOCK THE ACTIVATION OF TRANSCRIPTION FACTORS THROUGH INHIBITION OF A FAMILY OF SPECIFIC KINASES, DECREASING PROINFLAMMATORY PROTEINS TO TREAT AUTOIMMUNE DISEASES AND AS GENERAL ANTIINFLAMMATORY AGENTS SIGNAL PHARMACEUTICALS, INC. (US) 1999-08-10 — — US disclosed
WO-1998038171-A1 PYRIMIDINE CARBOXYLATES AND RELATED COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS SIGNAL PHARMACEUTICALS, INC. (US) 1998-09-03 — — WO disclosed
WO-1997009325-A1 PYRIMIDINE CARBOXYLATES AND RELATED COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS SIGNAL PHARMACEUTICALS, INC. (US) 1997-03-13 — — WO disclosed
Send feedback